Retatrutide is an investigational peptide currently being studied for its interaction with three key metabolic receptor pathways: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors
The Glucagon Effect Explained Retatrutide raises resting heart rate by approximately 57 bpm notably more than semaglutide or tirzepatide
Empagliflozin and cardiovascular outcomes in patients with type 2 diabetes and left ventricular hypertrophy: a subanalysis of the EMPA-REG OUTCOME trial
It also makes it simpler to follow routines for a long time
Similarly, the level of reduced glutathione was significantly lower in patients who took placebo (0.81 0.53 pg/ml) compared to the level of reduced glutathione in patients who took glutathione (1.71 0.43 pg/ml, p value 0.000)
In addition, because they delay gastric emptying, they can have a negative effect on anaesthetic outcomes when going in for surgery